Kiromic BioPharma (KRBP) IPO Opens Modestly Lower

Today's IPO for Kiromic BioPharma, Inc. (NASDAQ: KRBP) opened for trading at $11.80 after pricing of its initial public offering of 1,250,000 shares of its common stock at a public offering price of $12.00 per share.

In addition, the Company has granted the underwriters a 45-day option to purchase up to an additional 187,500 shares of common stock at the initial public offering price, less the underwriting discount, to cover over-allotments.

ThinkEquity, a division of Fordham Financial Management, Inc. is acting as sole book-running manager for the offering. Paulson Investment Company, LLC is acting as co-manager for the offering.

Kiromic BioPharma is a target discovery and gene-editing company utilizing artificial intelligence and a proprietary neural network platform with a therapeutic focus on immuno-oncology,

You May Also Be Interested In

• SpaceX prices historic IPO at $135/share in largest ever new listing
• EquiDeFi's Direct Investment Model Adds Opportunities for Private Investing
• Parabilis Medicines closes $770.5 million IPO and concurrent private placement